{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T12:07:32Z","timestamp":1779451652893,"version":"3.53.1"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejog.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Obstetrics & Gynecology and Reproductive Biology"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.ejogrb.2026.114952","type":"journal-article","created":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T00:21:49Z","timestamp":1768004509000},"page":"114952","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["High-grade uterine cancer with ambiguous features \u2013 a clinicopathological study"],"prefix":"10.1016","volume":"318","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2336-9973","authenticated-orcid":false,"given":"Roy","family":"Kessous","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ofer","family":"Wiesel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacob","family":"Dreiher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mihai","family":"Meirovitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon","family":"Davidesko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yarden","family":"Kezerle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benzion","family":"Samueli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruthy","family":"Shaco-Levy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ejogrb.2026.114952_b0005","doi-asserted-by":"crossref","first-page":"S40","DOI":"10.1097\/PGP.0000000000000491","article-title":"High-grade endometrial carcinomas: morphologic and immunohistochemical features, diagnostic challenges and recommendations","volume":"38","author":"Murali","year":"2019","journal-title":"Int J Gynecol Pathol"},{"issue":"2","key":"10.1016\/j.ejogrb.2026.114952_b0010","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1038\/modpathol.2017.131","article-title":"Are the uterine serous carcinomas underdiagnosed? Histomorphologic and immunohistochemical correlates and clinical follow up in high-grade endometrial carcinomas initially diagnosed as high-grade endometrioid carcinoma","volume":"31","author":"Hu","year":"2018","journal-title":"Modern Pathol"},{"issue":"6","key":"10.1016\/j.ejogrb.2026.114952_b0015","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1097\/PAP.0b013e318234ab18","article-title":"Endometrial carcinomas: a review emphasizing overlapping and distinctive morphological and immunohistochemical features","volume":"18","author":"Bartosch","year":"2011","journal-title":"Adv Anat Pathol"},{"key":"10.1016\/j.ejogrb.2026.114952_b0020","series-title":"Gynecologic and Obstetric Pathology","author":"Zheng","year":"2019"},{"issue":"8","key":"10.1016\/j.ejogrb.2026.114952_b0025","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1097\/PAS.0b013e31825dd4b3","article-title":"The diagnosis of endometrial carcinomas with clear cells by gynecologic pathologists: an assessment of interobserver variability and associated morphologic features","volume":"36","author":"Fadare","year":"2012","journal-title":"Am J Surg Pathol"},{"issue":"6","key":"10.1016\/j.ejogrb.2026.114952_b0030","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1097\/PAS.0b013e31827f576a","article-title":"Poor interobserver reproducibility in the diagnosis of high-grade endometrial carcinoma","volume":"37","author":"Gilks","year":"2013","journal-title":"Am J Surg Pathol"},{"issue":"12","key":"10.1016\/j.ejogrb.2026.114952_b0035","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1038\/modpathol.2013.102","article-title":"Reproducibility of histological cell type in high-grade endometrial carcinoma","volume":"26","author":"Han","year":"2013","journal-title":"Modern Pathol"},{"issue":"4","key":"10.1016\/j.ejogrb.2026.114952_b0040","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1097\/PGP.0000000000000162","article-title":"Endometrial carcinomas with clear cells: a study of a heterogeneous group of tumors including interobserver variability, mutation analysis, and immunohistochemistry with HNF-1\u03b2","volume":"34","author":"Han","year":"2015","journal-title":"Int J Gynecol Pathol"},{"issue":"9","key":"10.1016\/j.ejogrb.2026.114952_b0045","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1097\/PAS.0b013e31828c63ed","article-title":"Histotype-genotype correlation in 36 high-grade endometrial carcinomas","volume":"37","author":"Hoang","year":"2013","journal-title":"Am J Surg Pathol"},{"issue":"5","key":"10.1016\/j.ejogrb.2026.114952_b0050","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1038\/sj.bjc.6603012","article-title":"Uterine papillary serous and clear cell carcinomas predict for poorer survival compared to grade 3 endometrioid corpus cancers","volume":"94","author":"Hamilton","year":"2006","journal-title":"Br J Cancer"},{"issue":"2","key":"10.1016\/j.ejogrb.2026.114952_b0055","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.ygyno.2015.09.001","article-title":"Canadian high-risk endometrial cancer (CHREC) consortium: Analyzing the clinical behavior of high-risk endometrial cancers","volume":"139","author":"Altman","year":"2015","journal-title":"Gynecol Oncol"},{"issue":"1","key":"10.1016\/j.ejogrb.2026.114952_b0060","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.ygyno.2011.07.030","article-title":"Should grade 3 endometrioid endometrial carcinoma be considered a type 2 cancer \u2013 a clinical and pathological evaluation","volume":"124","author":"Voss","year":"2012","journal-title":"Gynecol Oncol"},{"issue":"3","key":"10.1016\/j.ejogrb.2026.114952_b0065","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.ygyno.2013.03.011","article-title":"Comparative outcomes assessment of uterine grade 3 endometrioid, serous, and clear cell carcinomas","volume":"129","author":"Ayeni","year":"2013","journal-title":"Gynecol Oncol"},{"issue":"7","key":"10.1016\/j.ejogrb.2026.114952_b0070","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1097\/PAS.0b013e31802ee494","article-title":"Clinicopathologic analysis of 187 high-grade endometrial carcinomas of different histologic subtypes: similar outcomes belie distinctive biologic differences","volume":"31","author":"Soslow","year":"2007","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"10.1016\/j.ejogrb.2026.114952_b0075","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/1471-2407-4-94","article-title":"An electronic application for rapidly calculating Charlson comorbidity score","volume":"4","author":"Hall","year":"2004","journal-title":"BMC Cancer"},{"issue":"5","key":"10.1016\/j.ejogrb.2026.114952_b0080","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A new method of classifying prognostic comorbidity in longitudinal studies: development and validation","volume":"40","author":"Charlson","year":"1987","journal-title":"J Chronic Dis"},{"issue":"2","key":"10.1016\/j.ejogrb.2026.114952_b0085","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.ijgo.2009.02.010","article-title":"Revised FIGO staging for carcinoma of the endometrium","volume":"105","author":"Creasman","year":"2009","journal-title":"Int J Gynecol Obstet"},{"issue":"5","key":"10.1016\/j.ejogrb.2026.114952_b0090","doi-asserted-by":"crossref","first-page":"e85","DOI":"10.3802\/jgo.2023.34.e85","article-title":"FIGO staging of endometrial cancer 2023","volume":"34","author":"Berek","year":"2023","journal-title":"J Gynecol Oncol"},{"key":"10.1016\/j.ejogrb.2026.114952_b0095","doi-asserted-by":"crossref","unstructured":"Soslow RA, Wethington SL, Cesari M, et al. Clinicopathologic Analysis of Matched Primary and Recurrent Endometrial Carcinoma [Internet]. 2012. Available from: www.ajsp.com.","DOI":"10.1097\/PAS.0b013e318273591a"},{"issue":"1","key":"10.1016\/j.ejogrb.2026.114952_b0100","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1038\/modpathol.2009.153","article-title":"P53 overexpression in morphologically ambiguous endometrial carcinomas correlates with adverse clinical outcomes","volume":"23","author":"Garg","year":"2010","journal-title":"Modern Pathol"},{"issue":"2","key":"10.1016\/j.ejogrb.2026.114952_b0105","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1097\/01.pgp.0000179614.47838.82","article-title":"Transtubal spread of serous adenocarcinoma of the endometrium: an underrecognized mechanism of metastasis","volume":"25","author":"Snyder","year":"2006","journal-title":"Int J Gynecol Pathol"},{"issue":"1","key":"10.1016\/j.ejogrb.2026.114952_b0110","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s00428-010-0939-z","article-title":"Does high-grade endometrioid carcinoma (grade 3 FIGO) belong to type I or type II endometrial cancer? A clinical-pathological and immunohistochemical study","volume":"457","author":"Zannoni","year":"2010","journal-title":"Virchows Arch"},{"issue":"1","key":"10.1016\/j.ejogrb.2026.114952_b0115","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1006\/gyno.2000.5737","article-title":"The outcome of stage I-II clinically and surgically staged papillary serous and clear cell endometrial cancers when compared with endometrioid carcinoma","volume":"77","author":"Cirisano","year":"2000","journal-title":"Gynecol Oncol"},{"issue":"8","key":"10.1016\/j.ejogrb.2026.114952_b0120","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1038\/modpathol.3800620","article-title":"Immunophenotypic diversity of endometrial adenocarcinomas: Implications for differential diagnosis","volume":"19","author":"Reid-Nicholson","year":"2006","journal-title":"Modern Pathol"},{"issue":"4","key":"10.1016\/j.ejogrb.2026.114952_b0125","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1097\/PGP.0b013e3181cd6552","article-title":"High-Grade endometrial carcinoma: serous and grade 3 endometrioid carcinomas have different immunophenotypes and outcomes","volume":"29","author":"Alkushi","year":"2010","journal-title":"Int J Gynecol Pathol"},{"issue":"4","key":"10.1016\/j.ejogrb.2026.114952_b0130","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1097\/PGP.0000000000000243","article-title":"TP53 mutational spectrum in endometrioid and serous endometrial cancers","volume":"35","author":"Schultheis","year":"2016","journal-title":"Int J Gynecol Pathol"},{"issue":"S1","key":"10.1016\/j.ejogrb.2026.114952_b0135","doi-asserted-by":"crossref","first-page":"S45","DOI":"10.1038\/modpathol.2015.141","article-title":"Practical issues in the diagnosis of serous carcinoma of the endometrium","volume":"29","author":"Gatius","year":"2016","journal-title":"Modern Pathol"},{"issue":"4","key":"10.1016\/j.ejogrb.2026.114952_b0140","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1053\/j.semdp.2010.09.003","article-title":"Endometrial carcinomas with ambiguous features","volume":"27","author":"Soslow","year":"2010","journal-title":"Semin Diagn Pathol"},{"issue":"11","key":"10.1016\/j.ejogrb.2026.114952_b0145","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1038\/modpathol.3800950","article-title":"Identification of prognostically relevant and reproducible subsets of endometrial adenocarcinoma based on clustering analysis of immunostaining data","volume":"20","author":"Alkushi","year":"2007","journal-title":"Modern Pathol"},{"issue":"7","key":"10.1016\/j.ejogrb.2026.114952_b0150","doi-asserted-by":"crossref","DOI":"10.1016\/S1470-2045(13)70591-6","article-title":"Classification of endometrial carcinoma: more than two types","volume":"15","author":"Murali","year":"2014","journal-title":"Lancet Oncol"},{"issue":"2","key":"10.1016\/j.ejogrb.2026.114952_b0155","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.ygyno.2013.08.003","article-title":"MMR deficiency is common in high-grade endometrioid carcinomas and is associated with an unfavorable outcome","volume":"131","author":"Nelson","year":"2013","journal-title":"Gynecol Oncol"}],"container-title":["European Journal of Obstetrics & Gynecology and Reproductive Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211526000187?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211526000187?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T11:25:46Z","timestamp":1779449146000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301211526000187"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":31,"alternative-id":["S0301211526000187"],"URL":"https:\/\/doi.org\/10.1016\/j.ejogrb.2026.114952","relation":{},"ISSN":["0301-2115"],"issn-type":[{"value":"0301-2115","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"High-grade uterine cancer with ambiguous features \u2013 a clinicopathological study","name":"articletitle","label":"Article Title"},{"value":"European Journal of Obstetrics & Gynecology and Reproductive Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejogrb.2026.114952","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"114952"}}